Exosomes from senescent cells could revolutionize cancer therapy delivery

Cellular senescence—when cells stop dividing and enter an aging state—has emerged as a promising cancer treatment strategy, but its relationship with tiny cellular messengers called exosomes could unlock new therapeutic possibilities. This comprehensive review examines how exosomes from senescent cells influence cancer progression and treatment outcomes. Exosomes are small extracellular vesicles that cells use to communicate by transferring molecular cargo to nearby and distant cells. When cancer cells become senescent through chemotherapy or other treatments, they release exosomes that can dramatically alter the tumor microenvironment. These vesicles carry proteins, RNA, and other molecules that can either promote cancer progression or enhance treatment effectiveness. The research reveals that chemotherapeutic agents don't just kill cancer cells—they also induce senescence and trigger immune responses through exosome-mediated communication. This dual effect creates both opportunities and challenges for cancer therapy. On one hand, senescent cancer cells release factors that can promote drug resistance and tumor growth. On the other hand, scientists are learning to engineer exosomes as precision drug delivery vehicles that can target specific cells or cellular components with remarkable accuracy. The review explores the molecular mechanisms driving these processes and highlights how different therapeutic approaches can either eliminate cancer cells or inadvertently promote resistance. Understanding exosomal dynamics in senescent cells could lead to more effective combination therapies and novel drug delivery strategies that harness the body's natural cellular communication networks.